Analyst Conference Summaries

Biotechnology Investor Aids

Aprea Therapeutics
APRE

conference date: November 5, 2020 (press release only)

Aprea Therapeutics Cancer Therapy Platform Is Promising [July 21, 2020 at Seeking Alpha]

2020
Aprea
Therapeutics
Q1 2020 release
Aprea
Therapeutics
Q2 2020 release
Aprea
Therapeutics
Q3 2020 release
 
May 15, 2020 Aug. 11, 2020 Nov. 5, 2020  

Aprea Therapeutics (APRE) is a clinical-stage biotechnology company specializing in therapies for cancers with TP53 mutations.

Aprea Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 BIIB
 BMY
 CLDX
 EPZM
 GILD
 GLYC
 INO
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 SGEN
 TTPH
 VBLT
 VSTM
 XLNX
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2020 William P. Meyers